Stock Track | Indivior Soars 5% as Stifel Boosts Target Price to $36

Stock Track

Nov 04, 2025

Indivior PLC (INDV) shares are soaring in Monday's trading session, with the stock climbing 5.01% as of 11:08 AM. The pharmaceutical company's stock is experiencing significant bullish momentum, outperforming the broader market.

The surge in Indivior's stock price comes on the heels of a notable update from Stifel, a well-respected financial services firm. Stifel has raised its target price for Indivior from $28 to $36, representing a substantial increase in their valuation of the company. This upward revision in the target price has evidently sparked investor enthusiasm, driving the stock's impressive gains.

The increased target price from Stifel may suggest growing confidence in Indivior's business prospects and future performance. Investors are likely interpreting this as a positive signal about the company's potential for growth and profitability. As the trading day progresses, market participants will be closely watching to see if Indivior can maintain its momentum and if other analysts follow suit with similarly optimistic outlooks.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1135743947"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1135743947\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1135743947?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-04 00:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1135743947","market":"hk","top_or_hot":-1,"title":"Stock Track | Indivior Soars 5% as Stifel Boosts Target Price to $36","media":"Stock Track","content":"<p>Indivior PLC (INDV) shares are soaring in Monday's trading session, with the stock climbing 5.01% as of 11:08 AM. The pharmaceutical company's stock is experiencing significant bullish momentum, outperforming the broader market.</p>\n\n<p>The surge in Indivior's stock price comes on the heels of a notable update from Stifel, a well-respected financial services firm. Stifel has raised its target price for Indivior from $28 to $36, representing a substantial increase in their valuation of the company. This upward revision in the target price has evidently sparked investor enthusiasm, driving the stock's impressive gains.</p>\n\n<p>The increased target price from Stifel may suggest growing confidence in Indivior's business prospects and future performance. Investors are likely interpreting this as a positive signal about the company's potential for growth and profitability. As the trading day progresses, market participants will be closely watching to see if Indivior can maintain its momentum and if other analysts follow suit with similarly optimistic outlooks.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Indivior Soars 5% as Stifel Boosts Target Price to $36</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Indivior Soars 5% as Stifel Boosts Target Price to $36\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-04 00:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Indivior PLC (INDV) shares are soaring in Monday's trading session, with the stock climbing 5.01% as of 11:08 AM. The pharmaceutical company's stock is experiencing significant bullish momentum, outperforming the broader market.</p>\n\n<p>The surge in Indivior's stock price comes on the heels of a notable update from Stifel, a well-respected financial services firm. Stifel has raised its target price for Indivior from $28 to $36, representing a substantial increase in their valuation of the company. This upward revision in the target price has evidently sparked investor enthusiasm, driving the stock's impressive gains.</p>\n\n<p>The increased target price from Stifel may suggest growing confidence in Indivior's business prospects and future performance. Investors are likely interpreting this as a positive signal about the company's potential for growth and profitability. As the trading day progresses, market participants will be closely watching to see if Indivior can maintain its momentum and if other analysts follow suit with similarly optimistic outlooks.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INDV","symbol_name":"INDIVIOR PLC","start_time":0,"source_url":"","article_id":"1135743947","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1135743947","pubTimestamp":1762186219,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Indivior PLC (INDV) shares are soaring in Monday's trading session, with the stock climbing 5.01% as of 11:08 AM. The pharmaceutical company's stock is experiencing significant bullish momentum,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"INDV":"INDIVIOR PLC"},"translate_title":"个股追踪|Indivior飙升5%Stifel将目标价上调至36美元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INDV":1},"content_text":"Indivior PLC (INDV) shares are soaring in Monday's trading session, with the stock climbing 5.01% as of 11:08 AM. The pharmaceutical company's stock is experiencing significant bullish momentum, outperforming the broader market.\nThe surge in Indivior's stock price comes on the heels of a notable update from Stifel, a well-respected financial services firm. Stifel has raised its target price for Indivior from $28 to $36, representing a substantial increase in their valuation of the company. This upward revision in the target price has evidently sparked investor enthusiasm, driving the stock's impressive gains.\nThe increased target price from Stifel may suggest growing confidence in Indivior's business prospects and future performance. Investors are likely interpreting this as a positive signal about the company's potential for growth and profitability. As the trading day progresses, market participants will be closely watching to see if Indivior can maintain its momentum and if other analysts follow suit with similarly optimistic outlooks.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}